Latest Peplin news
09-June-09
Peplin Initiates Phase 3 Clinical Trials with PEP005 Gel in AK on Face and Scalp read more
28-May-09
Peplin's Positive Phase II AK Trial Results Published in JAAD read more
17-May-09
Positive Results for Peplin's First Phase III AK Trial read more
15-May-09
Peplin Results for the Quarter Ended 31 March 2009 read more
Cherrell Hirst AO MBBS BEdSt DUniv FAICD
Non-executive Director
Member of Audit and Risk Committee
Chairman of Performance and Remuneration Committee
Dr. Hirst has served as a member of our board of directors since August 2000. From August 2000 to October 2007, Dr. Hirst served as Chairman of our board of directors. Dr. Hirst is a medical doctor and until November 2001 was a practitioner in the area of breast cancer diagnosis. She serves as a director of Suncorp-Metway Ltd, a publicly-held banking, insurance, investment and superannuation company. Dr. Hirst was Chancellor of Queensland University of Technology from 1994 until September 2004.
Dr. Hirst received a M.B.B.S. and a B.Ed.St. from the University of Queensland.
Board of Directors
- Thomas Wiggans, Chairman and Chief Executive Officer
- Eugene Bauer MD, President and Chief Medical Officer
- Joshua Funder PhD, Non-executive Director
- Cherrell Hirst AO, Non-executive Director
- Gary Pace PhD, Non-executive Director
- Michael Spooner, Non-executive Director
- Jim Scopa, Non-executive Director